| +0.11 / +1.01%|
Syneron Medical Ltd. engages in the manufacture, research, development, marketing, and sales of advanced equipment for the aesthetic medical industry. It operates its business through Professional Aesthetic Devices (PAD) and Emerging Business Units (EBU) segments. The PAD segment deals with research, development marketing, and sales of aesthetic medical equipment. The EBU segment includes Rakuto Bio technologies Ltd., Light Instruments Ltd., Syneron Beauty, Inc., Fluorinex Active Ltd., and Syneron beauty's home use products. These products are provided in various countries throughout North America, Europe, Israel, and Asia Pacific. The company was founded by Shimon Eckhouse and Moshe Mizrahy in July 2000 and is headquartered in Yokneam Illit, Israel.
|Amit Meridor||President & Chief Executive Officer|
|Hugo Goldman||Chief Financial Officer|
|Jonathan T. Pearson||Executive VP-Topical Products Business Development|
|Sarit Soccary Ben Yochanan||Vice President-Strategy & Business Development|